DAVID MAZZO
Profile
First Name
: DAVID
Middle Name
:
Last Name
: MAZZO
Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER, DIRECTOR
RICHARD BERMAN, RICHARD J BERMAN, DREW BERNSTEIN, GREGORY B. BROWN, MICHAEL DAVIDSON, ROBERT DICKEY IV, MARTYN D. GREENACRE, STEVEN M. KLOSK, DOUGLAS LOSORDO, LARRY A MAY, DAVID J. MAZZO, STEVEN S MYERS, STEVEN S. MYERS, ANDREW L. PECORA, STEPHEN W. POTTER, ROBERT PRETI, ROBERT A. PRETI, CYNTHIA S. SCHWALM, ROBIN L SMITH, ROBIN L. SMITH, JOSEPH TALAMO, PETER TRABER, PETER G. TRABER, CATHERINE VACZY, CATHERINE M VACZY, ERIC WEI, ERIC H.C. WEI, MARK WEINREB, ANNE WHITAKER, JOSEPH D ZUCKERMAN
DIRECTOR
DIRECTOR
KENNETH CARTER, JOHN CONRON, CRISTINA CSIMMA, RICHARD DALY, STEPHANIE DIAZ, STEPHANIE C DIAZ, J.D. FINLEY, JD FINLEY, MARGERY FISCHBEIN, I. RICHARD GARR, RICHARD GARR, RICHARD I. GARR, MARY ANN GRAY, THOMAS HALLAM, KARL JOHE, MITCHELL JONES, JONATHAN LLOYD JONES, ROBERT MCRAE, JAMES NEAL, JAMES R NEAL, SCOTT OGILVIE, WILLIAM OLDAKER, HERBERT SLADE, SANDFORD SMITH, SANDFORD D. SMITH, CATHERINE SOHN, CATHERINE A. SOHN, ROBERT TRENSCHEL, BINXIAN WEI, STANLEY WESTREICH, DONALD WILLIAMS
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
2020-01-22
D
PHARMACEUTICALS
LABORATORY ANALYTICAL INSTRUMENTS [3826]
DECLINE TO DISCLOSE
Equity
2018-03-28
D
PHARMACEUTICALS
LABORATORY ANALYTICAL INSTRUMENTS [3826]
DECLINE TO DISCLOSE
Equity
2018-03-28
D
BIOTECHNOLOGY
SERVICES-MISC HEALTH + ALLIED SERVICES, NEC [8090]
$5,000,001 - $25,000,000
Equity
2016-09-14
